$ Value
$0
Shares
11,000
Price
$0
Filed
Feb 3
Insider
Name
Deferiere Raphael
Title
Chief Accounting Officer
CIK
0002071320
Roles
Transaction Details
Transaction Date
2026-02-02
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
11,000
Footnotes
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in four equal annual installments with the first such annual vesting being on February 2, 2027. | 1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 2, 2026.
Filing Info
Deferiere Raphael's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-02 | CNTA | A | $0 |
| 2026-02-02 | CNTA | A | $0 |
| 2025-06-02 | CNTA | A | $0 |
Other Insiders at CNTA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Weinhoff Gregory M
Chief Business Officer
|
— | $2.6M | 2026-03-26 |
|
Crowley John J
Chief Financial Officer
|
— | — | 2026-02-02 |
|
Kanes Stephen
Chief Medical Officer
|
— | — | 2026-02-02 |
|
Anderson Karen M.
Chief People Officer
|
— | $6.5M | 2026-03-26 |
|
HUSSAIN IQBAL J
Chief Legal Officer
|
— | $1.0M | 2026-02-02 |
|
Bush Tia L
Chief Technology & Quality Ofc
|
— | — | 2026-02-02 |
|
Deferiere Raphael
Chief Accounting Officer
|
— | — | 2026-02-02 |
|
Accardi Mario Alberto
Chief Executive Officer
|
— | — | 2026-02-02 |